亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Effect of metformin and metformin-sulfonylurea on lipid profile of type 2 diabetes mellitus patients: A cross-sectional study

作者
Rani Sauriasari,Fitriani Syawalia,Azizahwati Azizahwati
出处
期刊:Istanbul university journal of pharmacy [Istanbul University]
卷期号:52 (2): 114-120 被引量:1
标识
DOI:10.26650/istanbuljpharm.2022.957738
摘要

Background and Aims: In addition to lowering blood glucose levels, metformin also has a positive effect on the lipid profile by affecting gluconeogenesis and lipogenesis in the liver. Conversely, sulfonylurea is reported to possibly worsen the lipid profile and increase the risk of cardiovascular disease. Therefore, we would like to know whether there is a significant difference in the lipid profile of type 2 diabetes mellitus patients taking metformin as monotherapy and metformin-sulfonylurea as a combination since these two medicines are very commonly used in Indonesia. Methods: A cross-sectional study was performed on 88 patients with type 2 diabetes mellitus who were restricted on metformin or metformin-sulfonylurea for equal to or more than 1 year. Subjects on metformin (n=37) and metformin-sulfonylurea (n=51) were asked to fast for at least 8 hours before blood sampling. We measured the lipid parameters from subjects’ blood samples using a standardized enzymatic method. Results: All basic characteristics of the study subjects in these two groups were matched. We found that total cholesterol, LDL-cholesterol, and triglyceride were lower and HDL-cholesterol was higher in the metformin group than the metforminsulfonylurea group but not statistically significant (p>0.05). Multivariate analysis showed no significant differences for both therapies in any parameters before and after being adjusted by confounders. Only the increase in BMI contributed significantly to the increase in triglyceride. Conclusion: This study presents no statistical differences in lipid profile after ≥1 year consumption of metformin and metformin-sulfonylurea combination.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Ming完成签到 ,获得积分10
1秒前
Richard完成签到,获得积分10
4秒前
7秒前
香蕉觅云的应助被纯情的阁采纳,获得30
7秒前
科研通AI6.4的应助被纯情的阁采纳,获得10
8秒前
科研通AI6.3的应助被纯情的阁采纳,获得10
8秒前
科研通AI6.3的应助被纯情的阁采纳,获得10
8秒前
笙笙的应助被纯情的阁采纳,获得10
8秒前
王占雪完成签到 ,获得积分10
8秒前
Maestro_S的应助被纯情的阁采纳,获得30
8秒前
顺利夏云完成签到,获得积分10
13秒前
only完成签到 ,获得积分10
19秒前
英俊的未来完成签到 ,获得积分10
21秒前
22秒前
年轻靖巧完成签到,获得积分10
22秒前
25秒前
xl的应助被科研通管家采纳,获得10
26秒前
26秒前
26秒前
ldxghh发布了新的文献求助10
26秒前
27秒前
27秒前
27秒前
27秒前
脑洞疼的应助被2589采纳,获得10
33秒前
38秒前
欣喜香菇发布了新的文献求助10
43秒前
坦率黑米完成签到,获得积分10
43秒前
reece完成签到 ,获得积分10
43秒前
科研通AI6.4的应助被KKIII采纳,获得10
43秒前
芜湖发布了新的文献求助10
46秒前
47秒前
47秒前
科目三的应助被时尚的灵萱采纳,获得10
47秒前
可乐发布了新的文献求助10
50秒前
51秒前
yingpxdoctor发布了新的文献求助10
53秒前
54秒前
Louislee完成签到,获得积分10
54秒前
芜湖完成签到,获得积分10
55秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8172954
求助须知:如何正确求助?哪些是违规求助? 9565447
关于积分的说明 21780029
捐赠科研通 7764817
什么是DOI,文献DOI怎么找? 3431496
关于科研通互助平台的介绍 2555519
邀请新用户注册赠送积分活动 2476571